
Israel strikes leave 130 dead in Gaza
TDT | Agencies
Israel strikes leave 130 dead in Gaza Agencies Overnight Israeli airstrikes killed at least 130 Palestinians, mostly women and children, in the war-ravaged Gaza, local health officials said yesterday.
Gaza's Health Ministry said at least 464 Palestinians were killed in the week to yesterday as a result of Israel's escalated bombardment.
The deaths of at least 130 Palestinians overnight are in addition to that figure.
'Complete families were wiped off the civil registration record by (overnight) Israeli bombardment,' Khalil Al-Deqran, Gaza health ministry spokesperson, said.
The Israeli military had no immediate comment on the casualties.
On the other hand, Gaza civil defence spokesman Mahmud Bassal told AFP at least 50 people had been killed yesterday 'as a result of ongoing Israeli air strikes since the early hours'.
Pre-dawn attack
He said 22 people died and at least 100 others wounded in a pre-dawn attack on tents sheltering displaced Palestinians in Al-Mawasi in the southern Gaza Strip.
AFPTV footage showed people sifting through what was left of ruined shelters and rescuers treating the wounded.
'All my family members are gone. There is no one left,' said a distraught Warda al-Shaer amid the wreckage.
'The children were killed as well as their parents. My mother died too, and my niece lost her eye.'
The ministry said 31 children and 27 women were left dead and hundreds more wounded in Friday's airstrikes.
In southern Gaza, Israel struck the outskirts of Deir al-Balah and the city of Khan Younis. It said it hit anti-tank missile posts and military structures.
Three children and their grandfather were killed as they fled bombardment in Khan Younis, said the head of pediatrics at Nasser Hospital, Dr. Ahmed al-Farra. In northern Gaza, the attacks sent people fleeing from the Jabaliya refugee camp and the town of Beit Lahiya.
The attacks came as Israel prepares for a new ground offensive aimed at achieving 'operational control' in parts of Gaza.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Tribune
a day ago
- Daily Tribune
Man who let snakes bite him 200 times spurs new antivenom hope
AFP | Paris Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be m o r e careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. B u t l a s t month, a study pub - lished in the prest i g i o u s Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. 'Pain every time' Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. 'Proud' For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said.


Daily Tribune
2 days ago
- Daily Tribune
Israel says Gaza rescuer spokesman linked to Hamas, claim denied
AFP | Jerusalem, Undefined Israel's army on Sunday accused the spokesman for Gaza's civil defence, a rescue group operating in the war-ravaged Palestinian territory, of being a Hamas "terrorist" -- an allegation he denied. Citing documents found during its forces' Gaza offensive, the military said Mahmud Bassal was "an active terrorist" in the Islamist militant group whose October 2023 attack on Israel sparked the Gaza war. It issued copies of what it said were Hamas membership lists to the media, without clarifying where or how the undated documents were obtained. The Israeli military accused Bassal of serving Hamas's objectives by spreading false and unverified information about its operations in Gaza. "This is a false accusation," Bassal told AFP. "I do not work for any military organisation," he said, adding that the agency's mission was guided by international law. The civil defence agency has operated in the Gaza Strip for decades, deploying rescuers to rush victims of Israeli air strikes to hospital. The organisation is often cited by international media outlets. With access restricted and conditions on the ground chaotic, it remains nearly impossible to independently verify casualty figures or the circumstances of deaths reported by the agency. The army's accusation comes as it faces criticism from the civil defence, which alleges Israeli forces recently killed civilians near food distribution centres. The war was sparked by Hamas's October 7, 2023 attack on Israel, which resulted in the deaths of 1,218 people on the Israeli side, mostly civilians, according to an AFP tally of official figures. On Saturday, the health ministry in Hamas-run Gaza said that the overall toll for the Gaza war had reached 54,772, the majority civilians. The UN considers these figures reliable.


Daily Tribune
6 days ago
- Daily Tribune
World Boxing Admits Error, Apologizes for Naming Khelif in Mandatory Sex Testing
TDT | Manama World Boxing has issued an apology after naming Algerian Olympic champion Imane Khelif in its announcement of mandatory sex testing for all competitors, acknowledging that her privacy was not adequately protected. The global governing body, recently granted provisional recognition to oversee boxing at the 2028 Olympics, now faces scrutiny over its handling of a sensitive issue. A Controversial Announcement Last week, World Boxing unveiled a new policy requiring all athletes over 18 to undergo a PCR genetic test to compete in its events. The test, which can be conducted via nasal or mouth swab, saliva, or blood, aims to standardise eligibility across the sport. However, the announcement drew attention for its specific reference to Khelif, stating that the Algerian Boxing Federation had been informed she 'may not participate in the female category' until complying with the testing requirement. The mention of Khelif, who won gold in the women's 66kg category at the Paris 2024 Olympics amid a gender eligibility controversy, sparked immediate backlash. The decision to single her out in a public statement raised questions about fairness and discretion in a sport already grappling with complex issues around gender and inclusion. An Apology from the Top In response, World Boxing president Boris van der Vorst took swift action. He personally wrote to Abdelkader Abbas, president of the Algerian Boxing Federation, to apologise for including Khelif's name in the announcement. A source confirmed that van der Vorst expressed regret, stating that the organisation should have taken greater care to safeguard Khelif's privacy. The apology reflects an acknowledgment that naming an individual in such a context risks amplifying personal and professional scrutiny. Efforts to reach Khelif and the Algerian Boxing Federation for comment were unsuccessful, leaving their perspective on the matter unclear. The Algerian federation, which joined World Boxing in September, is one of over 100 national bodies aligned with the organisation since its inception in 2023. Navigating a Sensitive Landscape The incident comes at a delicate time for boxing. Khelif's Olympic gold in Paris was a moment of pride for Algeria but was overshadowed by debates over gender eligibility, with some questioning her participation in the women's category. World Boxing's new testing policy appears designed to address such controversies with a consistent framework, but its implementation has stumbled out of the gate. The PCR test, described as a straightforward genetic screening process, is intended to ensure clarity and fairness in competition. Yet, by publicly linking the policy to Khelif, World Boxing inadvertently placed her back in the spotlight, reigniting discussions from the Paris Games. The organisation's apology signals an awareness of the need for greater sensitivity in handling such matters, particularly for athletes already navigating intense public scrutiny. A Test for Boxing's Future As World Boxing prepares to lead the sport into the 2028 Olympics, this episode highlights the challenges of balancing transparency, fairness, and respect for athletes' dignity. The organisation's provisional recognition by the International Olympic Committee is a significant step toward unifying boxing's fractured governance, but incidents like this highlight the complexities involved. For Khelif, the focus remains on her achievements in the ring, where she proved her dominance in Paris. How World Boxing moves forward—ensuring policies are applied equitably while protecting athletes' privacy—will be critical to maintaining trust among federations and competitors alike. For now, the sport's governing body has learned a hard lesson: clarity in policy must be matched by care in communication.